While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026, according to a new report from financial services firm Atradius. More: Global pharma manufacturing
read more
The vaccine could be created as a ready-to-use product, rather than needing to be personalised More: ErVimmune raises 17m euros in funding to develop cancer vaccine Source: News
read more
The PM Awards celebrate creativity in pharmaceutical marketing and healthcare communications More: Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026 Source: News
read moreAs Lindsey Vonn’s comeback run heads toward a peak with Team USA at the upcoming 2026 Winter Olympics, Invivyd is adding the professional skier to its team, too. More: Invivyd teams up with Olympic skier Lindsey Vonn for antibody education
read moreThe project, which involves Merck, SK Bioscience, Hilleman Laboratories and CDMO IDT Biologika, aims to make Merck’s current Ebola vaccine easier to manufacture and store, prompting broader global accessibility. More: CEPI bankrolls M Ebola vaccine collaboration with Merck, SK Bioscience
read moreDespite falling short in its recent bid to snatch Avadel from Alkermes, Lundbeck is signaling to investors that it’s not desperate for deals and will not lower its standards for future M&A transactions. More: Lundbeck ‘not willing to compromise’ on
read more© 1994 - 2026 B.M. Pharmaceuticals